Trial Profile
A safety and efficacy trial of recombinant human thrombopoietin in patients with severe sepsis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Thrombopoietin (Primary)
- Indications Sepsis
- Focus Therapeutic Use
- 02 Dec 2015 New trial record